TNFα and IL-6, through classical receptor-mediated processes, stimulate both the JNK and the IκB kinase-β (IKK-β)/(NF-κB) pathways, leading to upregulation of inflammation mediators, and further to insulin resistance [138,140,141] (Figure 3). The gene discussed is IL6; the disease is Insulin resistance.